elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33737691-6CA820D2-89AE-46C5-8303-A80E7A5EBCEB
Q33737691-6CA820D2-89AE-46C5-8303-A80E7A5EBCEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33737691-6CA820D2-89AE-46C5-8303-A80E7A5EBCEB
Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy
P2093
Q33737691-6CA820D2-89AE-46C5-8303-A80E7A5EBCEB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33737691-6CA820D2-89AE-46C5-8303-A80E7A5EBCEB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
335bdc092c5c85ba4c4a52e53b9eae87d5e4f883
P1545
12
http://www.w3.org/2001/XMLSchema#string
P2093
Masafumi Matsuo
http://www.w3.org/2001/XMLSchema#string